AI assistant
ABBOTT LABORATORIES — Director's Dealing 2012
Dec 4, 2012
29777_dirs_2012-12-04_2689db33-0611-4ca3-b761-738429060eda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-12-01
Reporting Person: ALBAN CARLOS (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-16 | Common shares without par value | G | 40442 | — | Disposed | 77243 | Direct |
| 2012-12-01 | Common shares without par value | A | 18453 | — | Acquired | 95696 | Direct |
| 2012-11-16 | Common shares without par value | G | 40442 | — | Acquired | 40442 | Indirect |
Footnotes
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards will cliff vest after January 1, 2016, subject to AbbVie reaching a minimum average return on equity target for the period 2013 through 2015. The awards include the right to have stock withheld for tax purposes.
F2: Held in the Maria Cristina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.